DeepTek CXR Analyzer vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DeepTek CXR Analyzer

by DeepTek

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

DeepTek CXR Analyzer is designed for AI-powered detection of a broad range of findings on chest X-rays, aiming to improve efficiency for general CXR interpretation. ClearRead CT, conversely, specializes in advanced pulmonary nodule detection and coronary artery calcification scoring specifically on CT scans. While both enhance cardiothoracic imaging workflows for radiologists, their core utility is differentiated by the imaging modality they process.

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if your primary need is to enhance the efficiency and accuracy of high-volume chest X-ray interpretations. This tool excels at providing rapid, AI-powered computer-assisted detection (CADe) for a broad spectrum of lung, pleural, and cardiac pathologies, significantly reducing radiologist workload and boosting overall productivity for initial screenings and general diagnostic support.

View DeepTek CXR Analyzer →

Choose ClearRead CT if…

Choose ClearRead CT if your focus is on advanced, detailed analysis of CT scans, particularly for pulmonary nodule detection, characterization, and tracking, as well as coronary artery calcification scoring. Its patented vessel suppression and automated nodule tracking features are ideal for precise lung cancer screening programs and cardiovascular risk assessments requiring longitudinal comparison and accurate measurements.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DeepTek CXR Analyzer	ClearRead CT
Pricing	Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.	Contact for pricing
Deployment	On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.	On-premise (stand-alone server, virtual machine) and Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ClearRead CT

Both tools emphasize seamless PACS integration to minimize workflow disruption. However, ClearRead CT explicitly highlights 'no separate viewer, logins, or extra clicks' and 'concurrent reading' as key features for an efficient workflow, supported by user testimonials. DeepTek CXR Analyzer also focuses on easy interpretation and no workflow changes, but ClearRead CT's specific claims about concurrent reading and lack of additional steps give it a slight edge in demonstrated usability.

Clinical Value

ClearRead CT

Both are FDA-cleared and demonstrate strong clinical value in their respective domains. DeepTek CXR Analyzer shows significant improvements in radiologist workload, productivity, and diagnostic accuracy for chest X-rays across 28 findings. ClearRead CT, however, provides more specific and quantifiable improvements in nodule detection accuracy (29% reduction in missed nodules) and reading time (up to 36% faster) for CT scans, along with advanced features like patented vessel suppression and automated nodule tracking and CAC scoring.

Pricing & Value

DeepTek CXR Analyzer

Both tools require contacting sales for pricing details. However, DeepTek CXR Analyzer explicitly states a 'Pay-per-use' model and offers flexibility as a technology offering or an AI-assisted reporting service, providing more transparency about its pricing structure upfront. While ClearRead CT also indicates a subscription model based on the number of analyses, DeepTek's clearer articulation of its flexible pay-per-use model gives it an advantage in pricing transparency.

Enterprise Readiness

DeepTek CXR Analyzer

Both tools are FDA-cleared and support both cloud and on-premise deployments with seamless PACS integration. DeepTek CXR Analyzer explicitly states HIPAA compliance and BAA availability, along with GDPR compliance and significant global adoption across over 500 hospitals. ClearRead CT, while indicating operation with VA and other healthcare institutions and enterprise-wide capability, is less explicit about BAA and HIPAA in its primary description.

Innovation

ClearRead CT

Both leverage AI for significant advancements in medical imaging. DeepTek CXR Analyzer is a 'first-of-its-kind' FDA-cleared CADe solution for CXR, offering broad detection of 28 findings and intelligent scan segregation. ClearRead CT, however, showcases more specific and patented innovations like 'Vessel Suppression' for improved nodule conspicuity, automated nodule tracking with comparison to prior exams, and CAC scoring on ungated, non-contrast CTs, which are highly specialized advancements for CT analysis.

Support & Docs

DeepTek CXR Analyzer

Neither tool's structured facts explicitly detail support or documentation. However, DeepTek's website explicitly mentions '140+ Experts delivering 24x7 services,' indicating a robust and readily available support infrastructure. Both companies provide access to publications, white papers, and case studies for documentation and validation purposes.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DeepTek CXR Analyzer	ClearRead CT
Tool Name	DeepTek CXR Analyzer	ClearRead CT
Company	DeepTek Medical Imaging Pvt	RIVERAIN TECHNOLOGIES
Description	DeepTek CXR Analyzer is an FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy.	ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology.
Primary Modality	Chest X-ray	CT scans
Key Features (Selection)	AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays, Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware, Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs)	Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth)

Videos

Demos, reviews, and walkthroughs featuring DeepTek CXR Analyzer and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do DeepTek CXR Analyzer and ClearRead CT integrate into a typical radiology workflow, and what are their primary clinical use cases given their differing modalities?

DeepTek CXR Analyzer is designed for initial chest X-ray analysis, providing AI-powered computer-assisted detection (CADe) for 28 pathologies to enhance diagnostic accuracy and workflow efficiency for CXRs. ClearRead CT specializes in detailed CT analysis for pulmonary nodule detection, characterization, and tracking, as well as coronary artery calcification (CAC) scoring, making it ideal for specific cardiothoracic CT assessments and follow-ups.

Can you elaborate on the reported accuracy and sensitivity of each tool, particularly how DeepTek CXR Analyzer's broad CXR findings compare to ClearRead CT's specialized nodule detection in terms of clinical impact?

DeepTek CXR Analyzer aims to significantly improve diagnostic accuracy across 28 CXR findings, with studies showing improved sensitivity and AUROC for detecting suspicious regions in lungs, pleura, and cardiac areas. ClearRead CT specifically reports a 29% reduction in missed actionable nodules and up to 36% reduced reading time for CT scans, highlighting its high precision in specialized pulmonary nodule detection and characterization.

Beyond seamless PACS integration, what level of integration can physicians expect with existing Electronic Health Record (EHR) systems for both tools, especially regarding the transfer of AI-generated findings or structured reports?

Both tools emphasize seamless DICOM-based PACS integration for image and AI output transfer, operating in the background without altering current workflows. While DeepTek mentions integration with HIS/RIS/PACS, and ClearRead CT mentions integration with radiology reports and HL7, further vendor-specific details would be needed to understand the current capabilities for deeper EHR integration and direct population of structured reports.

What is the typical learning curve for radiologists to become proficient with each system, and how quickly can a practice expect to realize the promised benefits in terms of efficiency and diagnostic improvement?

DeepTek CXR Analyzer's output as secondary capture DICOM with highlighted regions of interest suggests a straightforward integration into existing reading workflows, potentially leading to rapid adoption and productivity boosts of 2x-3x. ClearRead CT's vessel suppression and automated nodule tracking features are designed to streamline interpretation and reduce reading times by up to 36%, implying a quick realization of efficiency gains once integrated into the PACS workflow without needing a separate viewer.

What audit-trail capabilities do these AI tools provide to track how AI findings are reviewed, accepted, or modified by radiologists, supporting quality assurance and accountability?

DeepTek CXR Analyzer generates secondary capture DICOM with AI output, which can be integrated into existing PACS workflows, allowing for tracking within the PACS system. ClearRead CT's automated nodule tracking and comparison to prior exams inherently create a record of AI analysis over time, and its findings are automatically integrated into the radiology report, but explicit audit-trail features for radiologist interaction would require further inquiry.

For healthcare systems with multiple imaging sites, what are the key considerations for deploying and managing either DeepTek CXR Analyzer or ClearRead CT across different locations, ensuring consistent performance and support?

Both tools offer seamless PACS integration, which is crucial for multi-site deployments. DeepTek CXR Analyzer's compatibility with various X-ray modalities and deployment options (on-premise or cloud) suggests flexibility across different site setups, while ClearRead CT's enterprise-wide capability on every CT device and universal integration with patient data management programs would also support scalable implementation.